178 related articles for article (PubMed ID: 6358156)
41. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
42. Combination of 60Co gamma-radiation, misonidazole, and maltose tetrapalmitate in the treatment of Dunning prostatic tumor in the rat.
Pageau R; Nigam VN; Fisher GJ; Brailovsky CA; Fathi MA; Corcos J; Tahan TW; Elhilali MM
Int J Radiat Oncol Biol Phys; 1985 Aug; 11(8):1483-7. PubMed ID: 4019272
[TBL] [Abstract][Full Text] [Related]
43. [Radiosensitization of hypoxic tumor cells with special reference to head and neck cancers].
Kogelnik HD
Wien Klin Wochenschr; 1983 Aug; 95(15):515-8. PubMed ID: 6636784
[TBL] [Abstract][Full Text] [Related]
44. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer).
Van den Bogaert W; van der Schueren E; Horiot JC; Chaplain G; Arcangeli G; Gonzalez D; Svoboda V
Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1649-55. PubMed ID: 7153077
[TBL] [Abstract][Full Text] [Related]
45. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
Siemann DW; Hill SA
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
[TBL] [Abstract][Full Text] [Related]
46. Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward?
Urtasun RC; Coleman CN; Wasserman TH; Phillips TL
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1691-6. PubMed ID: 6237083
[TBL] [Abstract][Full Text] [Related]
47. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
Nelson DF; Schoenfeld D; Weinstein AS; Nelson JS; Wasserman T; Goodman RL; Carabell S
Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1143-51. PubMed ID: 6347995
[TBL] [Abstract][Full Text] [Related]
48. The effect of a hypoxic cell sensitizer on cancer radiotherapy: an analysis by a model.
Okumura Y; Okajima S
Strahlentherapie; 1984 Oct; 160(10):620-3. PubMed ID: 6495356
[TBL] [Abstract][Full Text] [Related]
49. Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report.
Shin KH; Urtasun RC; Fulton D; Geggie PH; Tanasichuk H; Thomas H; Muller PJ; Curry B; Mielke B; Johnson E
Cancer; 1985 Aug; 56(4):758-60. PubMed ID: 3893680
[TBL] [Abstract][Full Text] [Related]
50. The role of misonidazole combined with intraoperative radiation therapy in the treatment of pancreatic carcinoma.
Tepper JE; Shipley WU; Warshaw AL; Nardi GL; Wood WC; Orlow EL
J Clin Oncol; 1987 Apr; 5(4):579-84. PubMed ID: 3559650
[TBL] [Abstract][Full Text] [Related]
51. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
[TBL] [Abstract][Full Text] [Related]
52. Sensitizers and radiation dose fractionation: results and interpretations.
Hill RP
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1049-54. PubMed ID: 2943705
[TBL] [Abstract][Full Text] [Related]
53. [Clinical evaluation of misonidazole combined with radiotherapy in the treatment of carcinoma of the esophagus--a double-blind randomized trial].
Irie G; Sakurai T; Kikuchi Y; Watari T; Ikeda M; Mochizuki S; Kamata R; Kaneda K; Mikuriya S; Sakura M
Nihon Gan Chiryo Gakkai Shi; 1984 Oct; 19(9):2085-92. PubMed ID: 6397547
[No Abstract] [Full Text] [Related]
54. Response of an experimental mammary carcinoma to fractionated X-irradiation with misonidazole and microwave hyperthermia.
Goldfeder A; Brown DM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1287-91. PubMed ID: 6469752
[TBL] [Abstract][Full Text] [Related]
55. Effect of misonidazole in preoperative irradiation for bladder cancer followed by total cystectomy.
Ono K; Akuta K; Takahashi M; Abe M; Nishio Y; Okada K; Yoshida O
Radiat Med; 1989; 7(2):105-9. PubMed ID: 2508190
[TBL] [Abstract][Full Text] [Related]
56. Cytocidal effects of misonidazole, Ro 03-8799, and RSU-1164 on euoxic and hypoxic BP-8 murine sarcoma cells at normal and elevated temperatures.
Hofer KG; Lakkis M; Hofer MG
Cancer; 1989 Apr; 63(8):1501-8. PubMed ID: 2924258
[TBL] [Abstract][Full Text] [Related]
57. Misonidazole in the clinic at Mount Vernon.
Dische S
Cancer Clin Trials; 1980; 3(2):175-8. PubMed ID: 7000388
[TBL] [Abstract][Full Text] [Related]
58. Radiosensitizing effects of misonidazole and SR 2508 on a human melanoma transplanted in nude mice: influence on repair of potentially lethal damage.
Guichard M; Malaise EP
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):465-8. PubMed ID: 6213589
[TBL] [Abstract][Full Text] [Related]
59. A controlled trial of misonidazole in the curative treatment of infiltrating bladder cancer.
Bydder PV; Burry AF; Gowland S; Bourne RG; Chapman P; Firth LA; Gray AJ; McIlroy R
Australas Radiol; 1989 Feb; 33(1):8-14. PubMed ID: 2653300
[TBL] [Abstract][Full Text] [Related]
60. Clinical trials with hypoxic cell sensitizers-the European experience.
Dische S
Prog Clin Biol Res; 1983; 132D():293-303. PubMed ID: 6356146
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
